$PBIO Pressure BioSciences Invites Interested Inve
Post# of 1354
(Total Views: 132)
Posted On: 08/17/2023 10:51:26 AM
$PBIO Pressure BioSciences Invites Interested Investors to Attend a Webinar on the Health and Wellness Marvels of PBIO's Revolutionary UltraShear Platform
https://www.accesswire.com/774802/Pressure-Bi...r-Platform
Webinar Scheduled for 11:00AM ET on Thursday, August 17; Nearly 500 Registrants to Date.
SOUTH EASTON, MA / ACCESSWIRE / August 17, 2023 / Pressure BioSciences, Inc. (OTCQB
BIO) ("PBIO" or the "Company"
, a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables, and specialty testing services to the worldwide nutraceuticals, cosmeceuticals, food & beverage, pharmaceuticals, biotherapeutics, agrochemical, and other industries today announced that the Company's President and CEO (Mr. Richard T. Schumacher) and Director of Marketing & Sales (Mr. John B. Hollister) are the featured speakers at an online webinar scheduled for 11am ET on Thursday, August 17, 2023.
The webinar is entitled: "Health and Wellness Innovations: The Marvels of UltraShear™". During this webinar, you can expect to:
Gain a quick overview of Pressure BioSciences Inc. (OTCQB: PBIO) and its core technologies and products.
Learn about the powerful UltraShear platform and why it is viewed as a "Best-in-Class" processing system.
Explore UltraShear's transformative impact through its multiple applications in health & wellness.
Be inspired by life-changing experiences enjoyed by users of products processed by the UltraShear platform.
Have your questions answered during our interactive Q&A session.
Don't miss out on this chance to be part of the future of innovation in Health and Wellness! Register here to secure your spot and learn more about the webinar BIO Aug 17 Webinar Registration.
PBIO Recent News and Accomplishments
PBIO Reports Strongly Accelerating UltraShear Nano-CBD orders.
PBIO to Evaluate Company's Patented UltraShear Process to Extend Shelf-Life of Fresh Produce.
PBIO's UltraShear Nano-CBD Commercial Rollout Program Enters Rapid Expansion Phase 2.
Company Announces Nano-CBD Topical Spray Distribution Agreement with Crème de Canna.
Key Academic Publication Further Validates PBIO's UltraShear Platform's Impact on Clean-Label Foods.
PBIO Partners with Somalab Int'l for Development and Distribution of UltraShear-enabled health products.
Consumer Testing Validates Rapid Absorption/Effectiveness of UltraShear Nano-THC Spray
Mr. Richard T. Schumacher, PBIO's President and CEO, commented: "The combination of our UltraShear launch progress, the powerful enhancement that UltraShear offers in multiple billion-dollar industries, the impending publication of UltraShear bioavailability study results, and efforts focused on the improvement of our balance sheet and future revenue, provide a powerful forward-focused opportunity for our investors. We continue to work with multi-billion-dollar international conglomerates, well-funded startups, and many companies in between, as we facilitate the adoption of UltraShear. We believe our IP Estate is worth many times our current enterprise value. During my professional career, I have priorly founded/co-founded three successful public companies, yet in my opinion, none had close to the potential that we have in PBIO. For these and other reasons, we believe PBIO's future is both exciting and bright."
https://www.accesswire.com/774802/Pressure-Bi...r-Platform
Webinar Scheduled for 11:00AM ET on Thursday, August 17; Nearly 500 Registrants to Date.
SOUTH EASTON, MA / ACCESSWIRE / August 17, 2023 / Pressure BioSciences, Inc. (OTCQB
BIO) ("PBIO" or the "Company" , a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables, and specialty testing services to the worldwide nutraceuticals, cosmeceuticals, food & beverage, pharmaceuticals, biotherapeutics, agrochemical, and other industries today announced that the Company's President and CEO (Mr. Richard T. Schumacher) and Director of Marketing & Sales (Mr. John B. Hollister) are the featured speakers at an online webinar scheduled for 11am ET on Thursday, August 17, 2023. The webinar is entitled: "Health and Wellness Innovations: The Marvels of UltraShear™". During this webinar, you can expect to:
Gain a quick overview of Pressure BioSciences Inc. (OTCQB: PBIO) and its core technologies and products.
Learn about the powerful UltraShear platform and why it is viewed as a "Best-in-Class" processing system.
Explore UltraShear's transformative impact through its multiple applications in health & wellness.
Be inspired by life-changing experiences enjoyed by users of products processed by the UltraShear platform.
Have your questions answered during our interactive Q&A session.
Don't miss out on this chance to be part of the future of innovation in Health and Wellness! Register here to secure your spot and learn more about the webinar
BIO Aug 17 Webinar Registration. PBIO Recent News and Accomplishments
PBIO Reports Strongly Accelerating UltraShear Nano-CBD orders.
PBIO to Evaluate Company's Patented UltraShear Process to Extend Shelf-Life of Fresh Produce.
PBIO's UltraShear Nano-CBD Commercial Rollout Program Enters Rapid Expansion Phase 2.
Company Announces Nano-CBD Topical Spray Distribution Agreement with Crème de Canna.
Key Academic Publication Further Validates PBIO's UltraShear Platform's Impact on Clean-Label Foods.
PBIO Partners with Somalab Int'l for Development and Distribution of UltraShear-enabled health products.
Consumer Testing Validates Rapid Absorption/Effectiveness of UltraShear Nano-THC Spray
Mr. Richard T. Schumacher, PBIO's President and CEO, commented: "The combination of our UltraShear launch progress, the powerful enhancement that UltraShear offers in multiple billion-dollar industries, the impending publication of UltraShear bioavailability study results, and efforts focused on the improvement of our balance sheet and future revenue, provide a powerful forward-focused opportunity for our investors. We continue to work with multi-billion-dollar international conglomerates, well-funded startups, and many companies in between, as we facilitate the adoption of UltraShear. We believe our IP Estate is worth many times our current enterprise value. During my professional career, I have priorly founded/co-founded three successful public companies, yet in my opinion, none had close to the potential that we have in PBIO. For these and other reasons, we believe PBIO's future is both exciting and bright."
(0)
(0)Pressure Biosciences (PBIO) Stock Research Links
Scroll down for more posts ▼